Mark PB - Search Results

1

Serum phosphate and social deprivation independently predict all-cause mortality in chronic kidney disease.

Solbu MD, Thomson PC, Macpherson S, Findlay MD, Stevens KK, Patel RK, Padmanabhan S, Jardine AG, Mark PB. Solbu MD, et al. Among authors: mark pb. BMC Nephrol. 2015 Dec 1;16:194. doi: 10.1186/s12882-015-0187-1. BMC Nephrol. 2015. PMID: 26627078 Free PMC article.

2

Determinants of hypertension and left ventricular function in end stage renal failure: a pilot study using cardiovascular magnetic resonance imaging.

Stewart GA, Mark PB, Johnston N, Foster JE, Cowan M, Rodger RS, Dargie HJ, Jardine AG. Stewart GA, et al. Among authors: mark pb. Clin Physiol Funct Imaging. 2004 Nov;24(6):387-93. doi: 10.1111/j.1475-097X.2004.00583.x. Clin Physiol Funct Imaging. 2004. PMID: 15522049 Clinical Trial.

3

Electrocardiographic abnormalities and uremic cardiomyopathy.

Stewart GA, Gansevoort RT, Mark PB, Rooney E, McDonagh TA, Dargie HJ, Stuart R, Rodger C, Jardine AG. Stewart GA, et al. Among authors: mark pb. Kidney Int. 2005 Jan;67(1):217-26. doi: 10.1111/j.1523-1755.2005.00072.x. Kidney Int. 2005. PMID: 15610245 Free article.

4

Random blood glucose measurements and survival in nondiabetic renal transplant recipients.

Tutone VK, Mark PB, Revanur V, Traynor J, Buist LJ, Geddes CC, Deardon D, Jardine AG. Tutone VK, et al. Among authors: mark pb. Transplant Proc. 2004 Dec;36(10):3006-11. doi: 10.1016/j.transproceed.2004.10.067. Transplant Proc. 2004. PMID: 15686682

5

Hypertension, antihypertensive agents and outcomes following renal transplantation.

Tutone VK, Mark PB, Stewart GA, Tan CC, Rodger RS, Geddes CC, Jardine AG. Tutone VK, et al. Among authors: mark pb. Clin Transplant. 2005 Apr;19(2):181-92. doi: 10.1111/j.1399-0012.2004.00315.x. Clin Transplant. 2005. PMID: 15740553

6

Circulating endothelial cells in renal transplant recipients.

Mohamed AS, Thomson J, McDonald KJ, Hillyard DZ, Mark PB, Elliott HL, Jardine AG. Mohamed AS, et al. Among authors: mark pb. Transplant Proc. 2005 Jun;37(5):2387-90. doi: 10.1016/j.transproceed.2005.03.126. Transplant Proc. 2005. PMID: 15964423

7

Diagnostic potential of circulating natriuretic peptides in chronic kidney disease.

Mark PB, Stewart GA, Gansevoort RT, Petrie CJ, McDonagh TA, Dargie HJ, Rodger RS, Jardine AG. Mark PB, et al. Nephrol Dial Transplant. 2006 Feb;21(2):402-10. doi: 10.1093/ndt/gfi187. Epub 2005 Oct 12. Nephrol Dial Transplant. 2006. PMID: 16221702

8

Endothelial dysfunction in renal transplant recipients.

Mark PB, Murphy K, Mohammed AS, Morris ST, Jardine AG. Mark PB, et al. Transplant Proc. 2005 Nov;37(9):3805-7. doi: 10.1016/j.transproceed.2005.09.116. Transplant Proc. 2005. PMID: 16386545 Review.

9

Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.

Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, Steedman T, Dargie HJ, Jardine AG. Mark PB, et al. Kidney Int. 2006 May;69(10):1839-45. doi: 10.1038/sj.ki.5000249. Kidney Int. 2006. PMID: 16508657 Free article.

10

Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation.

Hillyard DZ, Nutt CD, Thomson J, McDonald KJ, Wan RK, Cameron AJ, Mark PB, Jardine AG. Hillyard DZ, et al. Among authors: mark pb. Atherosclerosis. 2007 Apr;191(2):319-25. doi: 10.1016/j.atherosclerosis.2006.05.037. Epub 2006 Jun 30. Atherosclerosis. 2007. PMID: 16814295

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters